Metabolites

OTHER2 trials

Sponsors

Corewell Health East, Academisch Medisch Centrum

Conditions

Lung Diseases, InterstitialPulmonary Fibrosisfatty liver disease Non-alcoholic fatty liver disease

Unknown Phase

Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases

TerminatedNCT04119115

Corewell Health EastLung Diseases, Interstitial, Pulmonary Fibrosis

Start: 2021-09-30End: 2022-10-20Updated: 2023-05-03

The Role of microbial produced ethanol in etiology of Non-Alcoholic Steatohepatitis (ETHANASH trial)

Active, not recruitingNL-OMON48065

Academisch Medisch Centrumfatty liver disease Non-alcoholic fatty liver disease

Start: 2019-05-03Target: 20Updated: 2024-02-28